Skip to main content
CGTX
NASDAQ Life Sciences

Cognition Therapeutics Secures Key Patent for Lead Drug Zervimesine, Extending Protection Through 2045

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.247
Mkt Cap
$108.293M
52W Low
$0.25
52W High
$3.83
52W Position info
399% above low
Off High info
67% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CGTX has more than doubled off its 52-week low of $0.25.

Summary

Cognition Therapeutics announced a Notice of Allowance for a new composition of matter patent covering a polymorphic crystalline form of its lead drug candidate, zervimesine (CT1812). This patent extends protection through 2045, with a potential extension to 2050, and covers a more stable formulation of the drug. This follows recent positive news regarding zervimesine, including successful FDA meetings in May and its formal advancement into a registrational program for Dementia with Lewy Bodies (DLB). Extending patent protection for a lead candidate by many years significantly enhances its long-term commercial value and de-risks its future revenue stream as it progresses into late-stage clinical development.

At the time of this announcement, CGTX was trading at $1.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $108.3M. The 52-week trading range was $0.25 to $3.83. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CGTX - Latest Insights

CGTX
Nov 05, 2026, 6:15 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.6833
Real-time Price: $0.640 info
Change: -$0.0433 (-6%) info
Market Cap: $59.904M info
CGTX
Nov 05, 2026, 6:04 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6833
Real-time Price: $0.640 info
Change: -$0.0433 (-6%) info
Market Cap: $59.904M info
CGTX
Oct 22, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.800
Real-time Price: $0.640 info
Change: -$0.160 (-20%) info
Market Cap: $59.904M info
CGTX
Oct 22, 2026, 6:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.7995
Real-time Price: $0.640 info
Change: -$0.1595 (-20%) info
Market Cap: $59.904M info
CGTX
Oct 13, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.865
Real-time Price: $0.640 info
Change: -$0.225 (-26%) info
Market Cap: $59.904M info